Chargement en cours...

The novel nicotinic receptor antagonist N,N′-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens

The current study examined the effect of the novel nicotinic acetylcholine receptor antagonist, N,N′-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), on nicotine-induced dopamine metabolism in rat nucleus accumbens, striatum and medial prefrontal cortex. Acute nicotine (0.5 mg/kg, s.c.) produ...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rahman, Shafiqur, Neugebauer, Nichole M., Zhang, Z., Crooks, Peter A., Dwoskin, Linda P., Bardo, Michael T.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2646104/
https://ncbi.nlm.nih.gov/pubmed/19000671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2008.10.037
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!